HB4621 EnrolledLRB103 36415 RLC 66517 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Substance Use Disorder Act is amended by
5changing Section 5-23 as follows:
 
6    (20 ILCS 301/5-23)
7    Sec. 5-23. Drug Overdose Prevention Program.
8    (a) Reports.
9        (1) The Department may publish annually a report on
10    drug overdose trends statewide that reviews State death
11    rates from available data to ascertain changes in the
12    causes or rates of fatal and nonfatal drug overdose. The
13    report shall also provide information on interventions
14    that would be effective in reducing the rate of fatal or
15    nonfatal drug overdose and on the current substance use
16    disorder treatment capacity within the State. The report
17    shall include an analysis of drug overdose information
18    reported to the Department of Public Health pursuant to
19    subsection (e) of Section 3-3013 of the Counties Code,
20    Section 6.14g of the Hospital Licensing Act, and
21    subsection (j) of Section 22-30 of the School Code.
22        (2) The report may include:
23            (A) Trends in drug overdose death rates.

 

 

HB4621 Enrolled- 2 -LRB103 36415 RLC 66517 b

1            (B) Trends in emergency room utilization related
2        to drug overdose and the cost impact of emergency room
3        utilization.
4            (C) Trends in utilization of pre-hospital and
5        emergency services and the cost impact of emergency
6        services utilization.
7            (D) Suggested improvements in data collection.
8            (E) A description of other interventions effective
9        in reducing the rate of fatal or nonfatal drug
10        overdose.
11            (F) A description of efforts undertaken to educate
12        the public about unused medication and about how to
13        properly dispose of unused medication, including the
14        number of registered collection receptacles in this
15        State, mail-back programs, and drug take-back events.
16            (G) An inventory of the State's substance use
17        disorder treatment capacity, including, but not
18        limited to:
19                (i) The number and type of licensed treatment
20            programs in each geographic area of the State.
21                (ii) The availability of medication-assisted
22            treatment at each licensed program and which types
23            of medication-assisted treatment are available.
24                (iii) The number of recovery homes that accept
25            individuals using medication-assisted treatment in
26            their recovery.

 

 

HB4621 Enrolled- 3 -LRB103 36415 RLC 66517 b

1                (iv) The number of medical professionals
2            currently authorized to prescribe buprenorphine
3            and the number of individuals who fill
4            prescriptions for that medication at retail
5            pharmacies as prescribed.
6                (v) Any partnerships between programs licensed
7            by the Department and other providers of
8            medication-assisted treatment.
9                (vi) Any challenges in providing
10            medication-assisted treatment reported by programs
11            licensed by the Department and any potential
12            solutions.
13    (b) Programs; drug overdose prevention.
14        (1) The Department may establish a program to provide
15    for the production and publication, in electronic and
16    other formats, of drug overdose prevention, recognition,
17    and response literature. The Department may develop and
18    disseminate curricula for use by professionals,
19    organizations, individuals, or committees interested in
20    the prevention of fatal and nonfatal drug overdose,
21    including, but not limited to, drug users, jail and prison
22    personnel, jail and prison inmates, drug treatment
23    professionals, emergency medical personnel, hospital
24    staff, families and associates of drug users, peace
25    officers, firefighters, public safety officers, needle
26    exchange program staff, and other persons. In addition to

 

 

HB4621 Enrolled- 4 -LRB103 36415 RLC 66517 b

1    information regarding drug overdose prevention,
2    recognition, and response, literature produced by the
3    Department shall stress that drug use remains illegal and
4    highly dangerous and that complete abstinence from illegal
5    drug use is the healthiest choice. The literature shall
6    provide information and resources for substance use
7    disorder treatment.
8        The Department may establish or authorize programs for
9    prescribing, dispensing, or distributing opioid
10    antagonists for the treatment of drug overdose. Such
11    programs may include the prescribing of opioid antagonists
12    for the treatment of drug overdose to a person who is not
13    at risk of opioid overdose but who, in the judgment of the
14    health care professional, may be in a position to assist
15    another individual during an opioid-related drug overdose
16    and who has received basic instruction on how to
17    administer an opioid antagonist.
18        (2) The Department may provide advice to State and
19    local officials on the growing drug overdose crisis,
20    including the prevalence of drug overdose incidents,
21    programs promoting the disposal of unused prescription
22    drugs, trends in drug overdose incidents, and solutions to
23    the drug overdose crisis.
24        (3) The Department may support drug overdose
25    prevention, recognition, and response projects by
26    facilitating the acquisition of opioid antagonist

 

 

HB4621 Enrolled- 5 -LRB103 36415 RLC 66517 b

1    medication approved for opioid overdose reversal,
2    facilitating the acquisition of opioid antagonist
3    medication approved for opioid overdose reversal,
4    providing trainings in overdose prevention best practices,
5    connecting programs to medical resources, establishing a
6    statewide standing order for the acquisition of needed
7    medication, establishing learning collaboratives between
8    localities and programs, and assisting programs in
9    navigating any regulatory requirements for establishing or
10    expanding such programs.
11        (4) In supporting best practices in drug overdose
12    prevention programming, the Department may promote the
13    following programmatic elements:
14            (A) Training individuals who currently use drugs
15        in the administration of opioid antagonists approved
16        for the reversal of an opioid overdose.
17            (B) Directly distributing opioid antagonists
18        approved for the reversal of an opioid overdose rather
19        than providing prescriptions to be filled at a
20        pharmacy.
21            (C) Conducting street and community outreach to
22        work directly with individuals who are using drugs.
23            (D) Employing community health workers or peer
24        recovery specialists who are familiar with the
25        communities served and can provide culturally
26        competent services.

 

 

HB4621 Enrolled- 6 -LRB103 36415 RLC 66517 b

1            (E) Collaborating with other community-based
2        organizations, substance use disorder treatment
3        centers, or other health care providers engaged in
4        treating individuals who are using drugs.
5            (F) Providing linkages for individuals to obtain
6        evidence-based substance use disorder treatment.
7            (G) Engaging individuals exiting jails or prisons
8        who are at a high risk of overdose.
9            (H) Providing education and training to
10        community-based organizations who work directly with
11        individuals who are using drugs and those individuals'
12        families and communities.
13            (I) Providing education and training on drug
14        overdose prevention and response to emergency
15        personnel and law enforcement.
16            (J) Informing communities of the important role
17        emergency personnel play in responding to accidental
18        overdose.
19            (K) Producing and distributing targeted mass media
20        materials on drug overdose prevention and response,
21        the potential dangers of leaving unused prescription
22        drugs in the home, and the proper methods for
23        disposing of unused prescription drugs.
24    (c) Grants.
25        (1) The Department may award grants, in accordance
26    with this subsection, to create or support local drug

 

 

HB4621 Enrolled- 7 -LRB103 36415 RLC 66517 b

1    overdose prevention, recognition, and response projects.
2    Local health departments, correctional institutions,
3    hospitals, universities, community-based organizations,
4    and faith-based organizations may apply to the Department
5    for a grant under this subsection at the time and in the
6    manner the Department prescribes. Eligible grant
7    activities include, but are not limited to, purchasing and
8    distributing opioid antagonists, hiring peer recovery
9    specialists or other community members to conduct
10    community outreach, and hosting public health fairs or
11    events to distribute opioid antagonists, promote harm
12    reduction activities, and provide linkages to community
13    partners.
14        (2) In awarding grants, the Department shall consider
15    the overall rate of opioid overdose, the rate of increase
16    in opioid overdose, and racial disparities in opioid
17    overdose experienced by the communities to be served by
18    grantees. The Department shall encourage all grant
19    applicants to develop interventions that will be effective
20    and viable in their local areas.
21        (3) (Blank).
22        (3.5) Any hospital licensed under the Hospital
23    Licensing Act or organized under the University of
24    Illinois Hospital Act shall be deemed to have met the
25    standards and requirements set forth in this Section to
26    enroll in the drug overdose prevention program upon

 

 

HB4621 Enrolled- 8 -LRB103 36415 RLC 66517 b

1    completion of the enrollment process except that proof of
2    a standing order and attestation of programmatic
3    requirements shall be waived for enrollment purposes.
4    Reporting mandated by enrollment shall be necessary to
5    carry out or attain eligibility for associated resources
6    under this Section for drug overdose prevention projects
7    operated on the licensed premises of the hospital and
8    operated by the hospital or its designated agent. The
9    Department shall streamline hospital enrollment for drug
10    overdose prevention programs by accepting such deemed
11    status under this Section in order to reduce barriers to
12    hospital participation in drug overdose prevention,
13    recognition, or response projects.
14        (4) In addition to moneys appropriated by the General
15    Assembly, the Department may seek grants from private
16    foundations, the federal government, and other sources to
17    fund the grants under this Section and to fund an
18    evaluation of the programs supported by the grants.
19    (d) Health care professional prescription of opioid
20antagonists.
21        (1) A health care professional who, acting in good
22    faith, directly or by standing order, prescribes or
23    dispenses an opioid antagonist to: (a) a patient who, in
24    the judgment of the health care professional, is capable
25    of administering the drug in an emergency, or (b) a person
26    who is not at risk of opioid overdose but who, in the

 

 

HB4621 Enrolled- 9 -LRB103 36415 RLC 66517 b

1    judgment of the health care professional, may be in a
2    position to assist another individual during an
3    opioid-related drug overdose and who has received basic
4    instruction on how to administer an opioid antagonist
5    shall not, as a result of his or her acts or omissions, be
6    subject to: (i) any disciplinary or other adverse action
7    under the Medical Practice Act of 1987, the Physician
8    Assistant Practice Act of 1987, the Nurse Practice Act,
9    the Pharmacy Practice Act, or any other professional
10    licensing statute or (ii) any criminal liability, except
11    for willful and wanton misconduct.
12        (1.5) Notwithstanding any provision of or requirement
13    otherwise imposed by the Pharmacy Practice Act, the
14    Medical Practice Act of 1987, or any other law or rule,
15    including, but not limited to, any requirement related to
16    labeling, storage, or recordkeeping, a health care
17    professional or other person acting under the direction of
18    a health care professional may, directly or by standing
19    order, obtain, store, and dispense an opioid antagonist to
20    a patient in a facility that includes, but is not limited
21    to, a hospital, a hospital affiliate, or a federally
22    qualified health center if the patient information
23    specified in paragraph (4) of this subsection is provided
24    to the patient. A person acting in accordance with this
25    paragraph shall not, as a result of his or her acts or
26    omissions, be subject to: (i) any disciplinary or other

 

 

HB4621 Enrolled- 10 -LRB103 36415 RLC 66517 b

1    adverse action under the Medical Practice Act of 1987, the
2    Physician Assistant Practice Act of 1987, the Nurse
3    Practice Act, the Pharmacy Practice Act, or any other
4    professional licensing statute; or (ii) any criminal
5    liability, except for willful and wanton misconduct.
6        (2) A person who is not otherwise licensed to
7    administer an opioid antagonist may in an emergency
8    administer without fee an opioid antagonist if the person
9    has received the patient information specified in
10    paragraph (4) of this subsection and believes in good
11    faith that another person is experiencing a drug overdose.
12    The person shall not, as a result of his or her acts or
13    omissions, be (i) liable for any violation of the Medical
14    Practice Act of 1987, the Physician Assistant Practice Act
15    of 1987, the Nurse Practice Act, the Pharmacy Practice
16    Act, or any other professional licensing statute, or (ii)
17    subject to any criminal prosecution or civil liability,
18    except for willful and wanton misconduct.
19        (3) A health care professional prescribing an opioid
20    antagonist to a patient shall ensure that the patient
21    receives the patient information specified in paragraph
22    (4) of this subsection. Patient information may be
23    provided by the health care professional or a
24    community-based organization, substance use disorder
25    program, or other organization with which the health care
26    professional establishes a written agreement that includes

 

 

HB4621 Enrolled- 11 -LRB103 36415 RLC 66517 b

1    a description of how the organization will provide patient
2    information, how employees or volunteers providing
3    information will be trained, and standards for documenting
4    the provision of patient information to patients.
5    Provision of patient information shall be documented in
6    the patient's medical record or through similar means as
7    determined by agreement between the health care
8    professional and the organization. The Department, in
9    consultation with statewide organizations representing
10    physicians, pharmacists, advanced practice registered
11    nurses, physician assistants, substance use disorder
12    programs, and other interested groups, shall develop and
13    disseminate to health care professionals, community-based
14    organizations, substance use disorder programs, and other
15    organizations training materials in video, electronic, or
16    other formats to facilitate the provision of such patient
17    information.
18        (4) For the purposes of this subsection:
19        "Opioid antagonist" means a drug that binds to opioid
20    receptors and blocks or inhibits the effect of opioids
21    acting on those receptors, including, but not limited to,
22    naloxone hydrochloride or any other similarly acting drug
23    approved by the U.S. Food and Drug Administration.
24        "Health care professional" means a physician licensed
25    to practice medicine in all its branches, a licensed
26    physician assistant with prescriptive authority, a

 

 

HB4621 Enrolled- 12 -LRB103 36415 RLC 66517 b

1    licensed advanced practice registered nurse with
2    prescriptive authority, an advanced practice registered
3    nurse or physician assistant who practices in a hospital,
4    hospital affiliate, or ambulatory surgical treatment
5    center and possesses appropriate clinical privileges in
6    accordance with the Nurse Practice Act, or a pharmacist
7    licensed to practice pharmacy under the Pharmacy Practice
8    Act.
9        "Patient" includes a person who is not at risk of
10    opioid overdose but who, in the judgment of the physician,
11    advanced practice registered nurse, or physician
12    assistant, may be in a position to assist another
13    individual during an overdose and who has received patient
14    information as required in paragraph (2) of this
15    subsection on the indications for and administration of an
16    opioid antagonist.
17        "Patient information" includes information provided to
18    the patient on drug overdose prevention and recognition;
19    how to perform rescue breathing and resuscitation; opioid
20    antagonist dosage and administration; the importance of
21    calling 911; care for the overdose victim after
22    administration of the overdose antagonist; and other
23    issues as necessary.
24    (e) Drug overdose response policy.
25        (1) Every State and local government agency that
26    employs a law enforcement officer or fireman as those

 

 

HB4621 Enrolled- 13 -LRB103 36415 RLC 66517 b

1    terms are defined in the Line of Duty Compensation Act
2    must possess opioid antagonists and must establish a
3    policy to control the acquisition, storage,
4    transportation, and administration of such opioid
5    antagonists and to provide training in the administration
6    of opioid antagonists. A State or local government agency
7    that employs a probation officer, as defined in Section 9b
8    of the Probation and Probation Officers Act, or a fireman
9    as defined in the Line of Duty Compensation Act but does
10    not respond to emergency medical calls or provide medical
11    services shall be exempt from this subsection.
12        (2) Every publicly or privately owned ambulance,
13    special emergency medical services vehicle, non-transport
14    vehicle, or ambulance assist vehicle, as described in the
15    Emergency Medical Services (EMS) Systems Act, that
16    responds to requests for emergency services or transports
17    patients between hospitals in emergency situations must
18    possess opioid antagonists.
19        (3) Entities that are required under paragraphs (1)
20    and (2) to possess opioid antagonists may also apply to
21    the Department for a grant to fund the acquisition of
22    opioid antagonists and training programs on the
23    administration of opioid antagonists.
24(Source: P.A. 101-356, eff. 8-9-19; 102-598, eff. 1-1-22.)
 
25    Section 10. The Pretrial Services Act is amended by

 

 

HB4621 Enrolled- 14 -LRB103 36415 RLC 66517 b

1changing Sections 1, 1.5, 2, 3, 4, 5, 8, 9, 10, 12, 13, 14, 15,
217, 22, 24, 30, and 33 and by adding Sections 0.02, 0.03, and
30.04 as follows:
 
4    (725 ILCS 185/0.02 new)
5    Sec. 0.02. Definitions. In this Act:
6    "Director" means the Director of the Office of Statewide
7Pretrial Services.
8    "Local pretrial services" means a pretrial services other
9than the Office who is providing pretrial services.
10    "Pretrial services" means any providing services to the
11circuit court as provided for in this Act, including the
12Office.
13    "Office" means the Office of Statewide Pretrial Services.
 
14    (725 ILCS 185/0.03 new)
15    Sec. 0.03. Office of Statewide Pretrial Services;
16establishment. There is established in the judicial branch of
17State government an office to be known as the Office of
18Statewide Pretrial Services. This office shall be under the
19supervision and direction of a Director who shall be appointed
20by a vote of a majority of the Illinois Supreme Court Justices
21for a 4-year term and until a successor is appointed and
22qualified. The Director shall adopt rules, instructions, and
23orders, consistent with this Act, further defining the
24organization of this office and the duties of its employees.

 

 

HB4621 Enrolled- 15 -LRB103 36415 RLC 66517 b

1The Illinois Supreme Court shall approve or modify an
2operational budget submitted to it by the Office of Statewide
3Pretrial Services and set the number of employees each year.
 
4    (725 ILCS 185/0.04 new)
5    Sec. 0.04. Powers and duties.
6    (a) The Office shall provide pretrial services as provided
7in Section 7 to circuit courts or counties without existing
8pretrial services agencies.
9    (b) The Office shall develop, establish, adopt, and
10enforce uniform standards for pretrial services in this State.
11    (c) The Office may:
12        (1) hire and train State employed pretrial personnel;
13        (2) establish qualifications for pretrial officers as
14    to hiring, promotion, and training;
15        (3) establish a system of training and orientation for
16    local pretrial services agencies;
17        (4) Develop standards and approve employee
18    compensation schedules for local pretrial services
19    agencies;
20        (5) establish a system of uniform forms;
21        (6) develop standards for a system of recordkeeping
22    for local pretrial services agencies;
23        (7) gather statistics and develop research for
24    planning of pretrial services in Illinois;
25        (8) establish a means of verifying the conditions for

 

 

HB4621 Enrolled- 16 -LRB103 36415 RLC 66517 b

1    reimbursement under this Act for local pretrial services
2    agencies and develop criteria for approved costs for
3    reimbursement;
4        (9) monitor and evaluate all pretrial programs
5    operated by local pretrial services agencies;
6        (10) review and approve annual plans submitted by
7    local pretrial services agencies; and
8        (11) establish such other standards and regulations
9    and do all acts necessary to carry out the intent and
10    purposes of this Act.
 
11    (725 ILCS 185/1)  (from Ch. 38, par. 301)
12    Sec. 1. Pretrial services shall be provided by a local
13pretrial services agency or the Office. The pretrial services
14agency shall provide Each circuit court shall establish a
15pretrial services agency to provide the circuit court with
16accurate background data regarding the pretrial release of
17persons charged with felonies and effective supervision of
18compliance with the terms and conditions imposed on release.
19(Source: P.A. 84-1449.)
 
20    (725 ILCS 185/1.5)
21    Sec. 1.5. Framework facilitating the hiring and training
22of new State-employed pretrial services personnel to serve
23circuit courts or counties without existing pretrial services
24agencies. Notwithstanding anything in this Act to the

 

 

HB4621 Enrolled- 17 -LRB103 36415 RLC 66517 b

1contrary, the Office shall hire Supreme Court is encouraged to
2establish a framework that facilitates the hiring and train
3training of new State-employed pretrial services personnel to
4serve circuit courts or counties without existing pretrial
5services agencies, as required by Section 1. Nothing in this
6amendatory Act of the 103rd General Assembly shall be
7constructed to invalidate, diminish, or otherwise interfere
8with any collective bargaining agreement or representation
9rights under the Illinois Public Labor Relations Act, if
10applicable.
11(Source: P.A. 102-694, eff. 1-7-22.)
 
12    (725 ILCS 185/2)  (from Ch. 38, par. 302)
13    Sec. 2. Local pretrial Pretrial services agencies may be
14independent divisions of the circuit courts accountable to the
15chief judge or his designee for program activities. The
16agencies shall be supervised by a program director appointed
17by the chief judge and removable for cause. The chief judge or
18his designee shall have the authority to hire, terminate or
19discipline local pretrial services agency personnel on
20recommendation of the program director.
21(Source: P.A. 84-1449.)
 
22    (725 ILCS 185/3)  (from Ch. 38, par. 303)
23    Sec. 3. Pretrial services shall be provided by the Office
24The functions of the pretrial services agency shall be

 

 

HB4621 Enrolled- 18 -LRB103 36415 RLC 66517 b

1assigned to the Department of Probation and Court Services or
2other arm of the court where the volume of criminal
3proceedings does not justify the establishment of a local
4pretrial services agency separate division.
5(Source: P.A. 84-1449.)
 
6    (725 ILCS 185/4)  (from Ch. 38, par. 304)
7    Sec. 4. All local pretrial services agency personnel shall
8be full-time employees supervised by the director and, except
9for secretarial staff, subject to the hiring and training
10requirements established by the Office Supreme Court as
11provided in "An Act providing for a system of probation, for
12the appointment and compensation of probation officers, and
13authorizing the suspension of final judgment and the
14imposition of sentence upon persons found guilty of certain
15defined crimes and offenses, and legalizing their ultimate
16discharge without punishment", approved June 10, 1911, as
17amended.
18(Source: P.A. 84-1449.)
 
19    (725 ILCS 185/5)  (from Ch. 38, par. 305)
20    Sec. 5. The compensation for local pretrial services
21agency personnel shall be commensurate with salaries and other
22benefits accorded probation department employees.
23(Source: P.A. 84-1449.)
 

 

 

HB4621 Enrolled- 19 -LRB103 36415 RLC 66517 b

1    (725 ILCS 185/8)  (from Ch. 38, par. 308)
2    Sec. 8. In addition to the foregoing, local pretrial
3services agencies may with the approval of the chief judge
4provide one or more of the following services to the circuit
5court:
6    (a) Supervise compliance with the terms and conditions
7imposed by the courts for appeal bonds; and
8    (b) Assist in such other pretrial services activities as
9may be delegated to the agency by the court.
10(Source: P.A. 84-1449.)
 
11    (725 ILCS 185/9)  (from Ch. 38, par. 309)
12    Sec. 9. Pretrial services agencies shall have standing
13court authority to interview and process all persons charged
14with non-capital felonies either before or after first
15appearance if the person is in custody. The chief judge and
16program director of the pretrial services agency may establish
17interviewing priorities where resources do not permit total
18coverage, but no other criteria shall be employed to exclude
19categories of offenses or offenders from program operations.
20(Source: P.A. 84-1449.)
 
21    (725 ILCS 185/10)  (from Ch. 38, par. 310)
22    Sec. 10. The chief judge and program director of the local
23pretrial services agency shall continuously assess the
24benefits of agency intervention before or after the first

 

 

HB4621 Enrolled- 20 -LRB103 36415 RLC 66517 b

1appearance of accused persons. In determining the best
2allocation of available resources, consideration shall be
3given to current release practices of first appearance judges
4in misdemeanor and lesser felony cases; the logistics of
5pre-first appearance intervention where decentralized
6detention facilities are utilized; the availability of
7verification resources for pre-first appearance intervention;
8and the ultimate goal of prompt and informed determinations of
9pretrial release conditions.
10(Source: P.A. 84-1449.)
 
11    (725 ILCS 185/12)  (from Ch. 38, par. 312)
12    Sec. 12. Interviews shall be individually conducted by
13agency personnel in facilities or locations which assure an
14adequate opportunity for discussion, consistent with security
15needs.
16    The chief judge or his designee shall maintain a
17continuous liaison between the pretrial services agency
18director and the sheriff, or other affected law enforcement
19agencies, to assure that pretrial services interviewers have
20prompt access consistent with security and law enforcement
21needs to all prisoners after booking.
22(Source: P.A. 84-1449.)
 
23    (725 ILCS 185/13)  (from Ch. 38, par. 313)
24    Sec. 13. Information received from the arrested person as

 

 

HB4621 Enrolled- 21 -LRB103 36415 RLC 66517 b

1a result of the agency interview shall be recorded on uniform
2interview forms created by the Office.
3(Source: P.A. 84-1449.)
 
4    (725 ILCS 185/14)  (from Ch. 38, par. 314)
5    Sec. 14. The pretrial services agency shall, after
6interviewing arrestees, immediately verify and supplement the
7information required by the uniform interview form before
8submitting its report to the court. Minimum verification shall
9include the interviewee's prior criminal record, residency,
10and employment circumstances. The chief judge or his designee
11shall assist the pretrial services agency program director in
12establishing and maintaining cooperation with the circuit
13clerk and law enforcement information systems to assure the
14prompt verification of prior criminal records.
15(Source: P.A. 84-1449.)
 
16    (725 ILCS 185/15)  (from Ch. 38, par. 315)
17    Sec. 15. Verified and supplemental information assembled
18by the pretrial services agency shall be recorded on a uniform
19reporting form established by the Office Supreme Court.
20(Source: P.A. 84-1449.)
 
21    (725 ILCS 185/17)  (from Ch. 38, par. 317)
22    Sec. 17. Reports shall be in writing, signed by an
23authorized representative of the pretrial services agency, and

 

 

HB4621 Enrolled- 22 -LRB103 36415 RLC 66517 b

1prepared on the uniform reporting form. Copies of the report
2shall be provided to all parties and counsel of record. If the
3report is filed with the court, the court shall deny public
4access to the report.
5(Source: P.A. 84-1449.)
 
6    (725 ILCS 185/22)  (from Ch. 38, par. 322)
7    Sec. 22. If so ordered by the court, the pretrial services
8agency shall prepare and submit for the court's approval and
9signature a uniform release order on the uniform form
10established by the Office Supreme Court in all cases where an
11interviewee may be released from custody under conditions
12contained in an agency report. Such conditions shall become
13part of the conditions of pretrial release. A copy of the
14uniform release order shall be provided to the defendant and
15defendant's attorney of record, and the prosecutor.
16(Source: P.A. 101-652, eff. 1-1-23.)
 
17    (725 ILCS 185/24)  (from Ch. 38, par. 324)
18    Sec. 24. Where functions of the local pretrial services
19agency have been delegated to a probation department or other
20arm of the court under Section 3, their records shall be
21segregated from other records. Two years after the date of the
22first interview with a pretrial services agency
23representative, the defendant may apply to the chief circuit
24judge, or a judge designated by the chief circuit judge for

 

 

HB4621 Enrolled- 23 -LRB103 36415 RLC 66517 b

1these purposes, for an order expunging from the records of the
2pretrial services agency all files pertaining to the
3defendant.
4(Source: P.A. 84-1449.)
 
5    (725 ILCS 185/30)  (from Ch. 38, par. 330)
6    Sec. 30. Records and statistics shall be maintained by
7local pretrial services agencies of their operations and
8effect upon the criminal justice system, with monthly reports
9submitted to the circuit court and the Office Supreme Court on
10a uniform statistical form developed by the Supreme Court.
11(Source: P.A. 84-1449.)
 
12    (725 ILCS 185/33)  (from Ch. 38, par. 333)
13    Sec. 33. The Office Supreme Court shall pay from funds
14appropriated to it for this purpose 100% of all approved costs
15for pretrial services, including pretrial services officers,
16necessary support personnel, travel costs reasonably related
17to the delivery of pretrial services, space costs, equipment,
18telecommunications, postage, commodities, printing and
19contractual services. Costs shall be reimbursed monthly, based
20on an annual a plan and budget approved by the Office Supreme
21Court. No department may be reimbursed for costs which exceed
22or are not provided for in the approved annual plan and budget.
23The Mandatory Arbitration Fund may be used to reimburse
24approved costs for pretrial services.

 

 

HB4621 Enrolled- 24 -LRB103 36415 RLC 66517 b

1(Source: P.A. 94-91, eff. 7-1-05; 94-839, eff. 6-6-06; 95-331,
2eff. 8-21-07; 95-707, eff. 1-11-08.)
 
3    (725 ILCS 185/6 rep.)
4    Section 15. The Pretrial Services Act is amended by
5repealing Section 6.
 
6    Section 99. Effective date. This Act takes effect upon
7becoming law, except that Sections 10 and 15 take effect on
8July 1, 2025.